- Home
- CZNC vs SMTI Comparison
CZNC vs SMTI Comparison
Compare CZNC & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZNC
- SMTI
- Stock Information
- Founded
- CZNC 1864
- SMTI 1982
- Country
- CZNC United States
- SMTI United States
- Employees
- CZNC N/A
- SMTI N/A
- Industry
- CZNC Major Banks
- SMTI Medical/Dental Instruments
- Sector
- CZNC Finance
- SMTI Health Care
- Exchange
- CZNC Nasdaq
- SMTI Nasdaq
- Market Cap
- CZNC 315.7M
- SMTI 288.2M
- IPO Year
- CZNC N/A
- SMTI N/A
- Fundamental
- Price
- CZNC $18.59
- SMTI $34.41
- Analyst Decision
- CZNC
- SMTI Strong Buy
- Analyst Count
- CZNC 0
- SMTI 2
- Target Price
- CZNC N/A
- SMTI $47.00
- AVG Volume (30 Days)
- CZNC 33.9K
- SMTI 32.2K
- Earning Date
- CZNC 10-17-2024
- SMTI 11-12-2024
- Dividend Yield
- CZNC 6.02%
- SMTI N/A
- EPS Growth
- CZNC N/A
- SMTI N/A
- EPS
- CZNC 1.44
- SMTI N/A
- Revenue
- CZNC $101,899,000.00
- SMTI $78,056,873.00
- Revenue This Year
- CZNC N/A
- SMTI $29.95
- Revenue Next Year
- CZNC $7.24
- SMTI $19.68
- P/E Ratio
- CZNC $12.96
- SMTI N/A
- Revenue Growth
- CZNC N/A
- SMTI 24.66
- 52 Week Low
- CZNC $16.50
- SMTI $26.00
- 52 Week High
- CZNC $23.50
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- CZNC 32.04
- SMTI 51.25
- Support Level
- CZNC $18.33
- SMTI $31.13
- Resistance Level
- CZNC $19.92
- SMTI $35.08
- Average True Range (ATR)
- CZNC 0.51
- SMTI 1.73
- MACD
- CZNC -0.19
- SMTI -0.12
- Stochastic Oscillator
- CZNC 8.02
- SMTI 60.60
About CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.